Avalo Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AVTX | AVLN | AUTL | AVCT.L | ACTI.ST | XLO | |
|---|---|---|---|---|---|---|
| Market cap | 379.16M | 1.22B | 367.30M | 247.70M | 101.49M | 57.31M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -2.5 | -10.6 | -2.2 | -21.0 | — | -15.0 |
| Price/book | 0.8 | 3.1 | 4.9 | 70.7 | 2.7 | 0.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −55.93% | −9.09% | +2.17% | −20.03% | −34.67% | −23.93% |
| Today | −2.48% | +2.46% | −2.47% | −1.57% | +4.62% | +0.35% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All AVTX news ›Avalo Therapeutics to Participate in Upcoming Investor Conferences
WAYNE, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today…
Avalo Therapeutics to present at two investor conferences in November 2026
Avalo Therapeutics, a biotech company focused on IL-1β pathway therapeutics for inflammatory diseases, announced its management will participate in the Guggenheim Healthcare Innovation Conference and the Stifel 2026 Healthcare Conference…
Avalo Therapeutics (NASDAQ:AVTX) and CRISPR Therapeutics (NASDAQ:CRSP) Critical Contrast
Posted by Mitch Edgeman on Oct 28th, 2026 CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) and Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two…
Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3
Avalo's positive LOTUS results now support a pivotal trial, and its monthly dosing gives it a potential differentiating factor in HS. Read why AVTX stock is a Buy. - Avalo Therapeutics' positive LOTUS results now support a pivotal trial,…
Avalo Therapeutics (NASDAQ:AVTX) Stock Rating Reaffirmed as “Neutral” by HC Wainwright
Posted by Kim Johansen on Oct 23rd, 2026 Avalo Therapeutics (NASDAQ:AVTX – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Friday, MarketBeat…
Praxis Precision Medicines (NASDAQ:PRAX) versus Avalo Therapeutics (NASDAQ:AVTX) Financial Contrast
Posted by Sarita Garza on Oct 23rd, 2026 Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) and Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare…
ValiRx highlights 5.55% Ambrose Healthcare stake following €161 million AM-Pharma acquisition
ValiRx Plc (AIM: VAL) has highlighted its indirect 5.55% shareholding in Ambrose Healthcare following the private pharmaceutical company’s agreement to acquire AM-Pharma for up to €161 million, drawing investor attention to the potential…
Avalyn Pharma Inc.'s Lock-Up Period Set To End on October 27th (NASDAQ:AVLN)
Get Our Latest Report on Avalyn Pharma NASDAQ:AVLN opened at $23.33 on Tuesday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 33.12 and a current ratio of 33.12. The stock has a market cap of $1.03 billion and a…
EssilorLuxottica (OTCMKTS:ESLOY) Sees Unusually-High Trading Volume – Here’s What Happened
Posted by Defense World Staff on Oct 18th, 2026 Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) saw unusually-strong trading volume on Friday. Approximately 388,174 shares traded hands during mid-day trading,…
Avalo Therapeutics (NASDAQ:AVTX) Stock Price Down 5.8% – Here’s What Happened
Shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) were down 5.8% during mid-day trading on Tuesday. The stock traded as low as $14.17 and last traded at $13.7560. 34,818 shares traded hands during trading, a decline of 97%…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com9
- defenseworld.net2
- manilatimes.net1
- marketbeat.com1
- pluang.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.